Cargando…
Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
BACKGROUND: Lycorine has been revealed to inhibit the development of many kinds of malignant tumors, including glioblastoma multiforme (GBM). Although compelling evidences demonstrated Lycorine’s inhibition on cancers through some peripheral mechanism, in-depth mechanism studies of Lycotine’s anti-G...
Autores principales: | Shen, Jia, Zhang, Tao, Cheng, Zheng, Zhu, Ni, Wang, Hua, Lin, Li, Wang, Zexia, Yi, Haotian, Hu, Meichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050662/ https://www.ncbi.nlm.nih.gov/pubmed/30016965 http://dx.doi.org/10.1186/s13046-018-0785-4 |
Ejemplares similares
-
In Vitro Inhibition of Alphaviruses by Lycorine
por: Li, Na, et al.
Publicado: (2021) -
Isomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis
por: Wang, Banghua, et al.
Publicado: (2018) -
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
por: Hu, Meichun, et al.
Publicado: (2015) -
Lycorine inhibits angiogenesis by docking to PDGFRα
por: Lv, Fei, et al.
Publicado: (2022) -
MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism
por: Yin, JianXing, et al.
Publicado: (2020)